HUMAN ROTAVIRUS INFECTION VACCINE BASED ON ROTAVIRUS VIRUS-LIKE PARTICLES
2024-04-07
专利权人FEDERAL STATE BUDGETARY INST (FSBI-C)
申请日期2024-04-07
专利号RU2829862-C1
成果简介NOVELTY - Invention relates to a rotavirus vaccine based on rotavirus virus-like particles. Vaccine contains recombinant virus-like particles (VLP), formed by nucleocapsid proteins VP2, VP6 and surface proteins VP4 and VP7 of 6 genotypes G1, G2, G4, G9, P4, P8 of rotavirus type A, synthesized in a baculovirus expression system—30–120 mcg; potassium dihydrophosphate—0.30 mg; disodium hydrogen phosphate—0.31 mg; sodium chloride—2.01 mg; potassium chloride—0.04 mg; calcium chloride—0.03 mg; tris(hydroxymethyl)aminomethane—0.04 mg; thiomersal—not more than 4.5 mcg; water-oil adjuvant based on squalene—0.25 ml, water for injections—up to 0.5 ml. USE - Biotechnology; immunology; virology. ADVANTAGE - Invention provides creating a vaccine which induces specific immunity against an infection caused by human rotavirus A. 4 cl, 6 dwg, 2 tbl, 5 ex
IPC 分类号A61K-039/15
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/17334
专题中国科学院新疆生态与地理研究所
作者单位
FEDERAL STATE BUDGETARY INST (FSBI-C)
推荐引用方式
GB/T 7714
GREBENNIKOVA T V,ELISEEVA O V,KOSTINA L V,et al. HUMAN ROTAVIRUS INFECTION VACCINE BASED ON ROTAVIRUS VIRUS-LIKE PARTICLES. RU2829862-C1[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。